
 |
 |

Diamondhead Ventures is a $140 million early-stage venture capital
fund specializing in bringing to market communications and computing
infrastructure technologies spinning out of leading research universities
and corporations. Diamondhead Ventures' investment team averages nearly
30 years' experience building and investing in successful companies.
Diamondhead Ventures' world-class advisory board and corporate partners
(including Sun, Oracle, and Fujitsu) provide the resources and strategic
partnerships entrepreneurs need to succeed. For more information,
visit www.dhven.com.
|
 |
 |

Earlybird is an international venture capital management company with
approximately $300 million in funds under management and an investment
focus on information technology, communication technology and healthcare.
With offices in Europe (Hamburg, Munich) and the U.S. (Palo Alto),
Earlybird is well positioned to take advantage of international opportunities
and helps itsportfolio companies gain access to the international
market place. Earlybird's investment professionals have extensive
finance and start-up operating experience, providing pro-active support
to their portfolio companies. In addition, an experienced network
of industry specialists serve on the Earlybird advisory board, assisting
Earlybird and its portfolio companies by providing strategic advice
and operational support. Additional information regarding Earlybird
can be found at www.earlybird.com.
|
 |
 |

EDBV Management Pte Ltd ("EDBVM") manages 10 venture capital and private
equity investment funds totaling approximately US$450 million. It
has made more than 100 investments to date in Singapore and overseas.
EDBVM is wholly owned by EDB Investments Pte Ltd ("EDBI") of Singapore
Economic Development Board ("EDB"). EDBVM's investments build successful
commercial enterprises and support EDB's thrusts in developing key
industry clusters, entrepreneurship, enterprise globalisation, and
emerging growth opportunities under EDB's charter. The funds under
management include EDB Ventures Pte Ltd, PLE Investments Pte Ltd,
M-Commerce Ventures Pte Ltd, M-Commerce Ventures II Pte Ltd, Fabless
Investments Pte Ltd and Pervasive Storage Investments Pte Ltd. EDBVM
works extensively with domestic and international co-investors, businesses
and entrepreneurs. For more information, visit www.edbvm.com.sgr
|
 |
 |

Partners Group is one of the largest alternative asset managers worldwide focussing on Private Equity and Hedge Funds. Its Head Office is situated in Zug, Switzerland, and it has representative offices in New York, Guernsey, London and Singapore. Partners Group is invested globally in more than 100 leading Private Equity partnerships as well as directly in companies of various financing stages and a range of Hedge Fund managers.
www.partnersgroup.net
|
 |
 |

Founded in Paris in 1972, Sofinnova Partners is one of Europe's leading
independent venture capital firms. With 550 million euros under management,
Sofinnova Partners invests in start-ups and early-stage companies
in information technology and life sciences. Its investment strategy
is based on two principles: Investing early in projects with a high
potential; and acting as lead or co-lead investor. Sofinnova's investment
team consists of 12 professionals, all recognized experts in their
field, who bring valuable market insight and technical expertise to
Sofinnova's portfolio companies. For more information, please visit
www.sofinnova.fr
|
 |
 |

San Francisco-based Sofinnova Ventures was founded in 1974. The firm
emphasizes a diversified investment strategy through financing seed
and early-stage companies in the life science and information technology
sectors. The firm's mission is to create value by providing entrepreneurs
with the collective resources, experience and network necessary to
build early-stage companies into profitable businesses. Historically,
Sofinnova has been associated with leading companies such as: Biogen,
Collagen, Genentech, Printronix, Tandon and Tandem Computers. More
recently, Sofinnova invested in Actelion, Aviron, Element 14, InterMune,
Millennium Pharmaceuticals, Phone.com, Premisys, Seattle Genetics
and Tumbleweed Communications. Sofinnova
Ventures currently has five partners and one venture partner,
with over $600 million under management. For more information, visit
www.sofinnova.com.
|
 |
|
 |